# Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?

> **NCT02443285** · PHASE3 · UNKNOWN · sponsor: **Tanta University** · enrollment: 100 (estimated)

## Conditions studied

- Primary Bacterial Peritonitis

## Interventions

- **DRUG:** Cefotaxime
- **DRUG:** ceftriaxone

## Key facts

- **NCT ID:** NCT02443285
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02443285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02443285, "Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02443285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*